Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 2;231(5):1101-1111.
doi: 10.1093/infdis/jiaf181.

Tuberculous Meningitis Across the Lifespan

Affiliations
Review

Tuberculous Meningitis Across the Lifespan

Rentia Lourens et al. J Infect Dis. .

Abstract

Tuberculous meningitis remains the most lethal form of tuberculosis. Despite significant physiological differences adults and children with tuberculous meningitis receive similar treatment and are often grouped together in research. Consequently, differences in tuberculous meningitis characteristics across the lifespan are poorly understood but may be relevant to developing more effective and age-appropriate interventions. In this review we discuss potential age-specific considerations in pathogenesis and pathophysiology, and review literature over the last 5 years to describe clinical characteristics, management, and outcomes across age groups. Children aged <5 years are vulnerable to tuberculosis disease and dissemination due to an immature immune system and the developing brain is highly susceptible to injury associated with neuroinflammation, leading to a greater likelihood of disability that has lifelong impact. Amongst adults, those with human immunodeficiency virus and older people are at greatest risk of death, but more research into the frequency of neurocognitive disability is needed.

Keywords: adults; children; outcome; pathogenesis; tuberculous meningitis.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Factors contributing to a vulnerability to tuberculous meningitis across the lifespan. Children have immature immune systems, making them more susceptible to developing active tuberculosis and dissemination of tuberculosis to the brain. The diagnosis of tuberculous meningitis is difficult, often resulting in delayed and severe presentation of the disease. This, together with the inflammatory process in the brain and risk of ischemia, lead to poor neurodevelopmental and neurocognitive outcomes. Adults with tuberculous meningitis are frequently coinfected with human immunodeficiency virus (HIV). The compromised immune system caused by HIV increases the risk of active tuberculosis disease and dissemination. The initiation of antiretroviral therapy to treat HIV puts tuberculous meningitis patients at risk to develop an immune reconstitution inflammatory syndrome (IRIS). Tuberculous meningitis IRIS, together with the ongoing inflammatory process in the brain, and the risk of ischemia leads to unfavorable outcomes. Older people are also at increased risk of late presentation and poor tuberculous meningitis outcomes. Created in BioRender. Rohlwink, U. (2025) https://BioRender.com/b86q069
Figure 2.
Figure 2.
Commonly reported characteristics of tuberculous meningitis. Clinical characteristics include fever, vomiting, a decreased level of consciousness, malnourishment, and seizures, headache, meningism, and signs of pulmonary tuberculosis. Imaging findings often show hydrocephalus, basal meningeal enhancement, and infarcts. Cerebrospinal fluid characteristics include elevated white blood cell count, lymphocyte predominance, and increased protein. Created in BioRender. Rohlwink, U. (2025) https://BioRender.com/a03y524

References

    1. World Health Organization . Global tuberculosis report 2024. Geneva: World Health Organization, 2024.
    1. Dodd PJ, Osman M, Cresswell FV, et al. The global burden of tuberculous meningitis in adults: a modelling study. PLOS Glob Public Health 2021; 1:e0000069. - PMC - PubMed
    1. Stadelman AM, Ellis J, Samuels THA, et al. Treatment outcomes in adult tuberculous meningitis: a systematic review and meta-analysis. Open Forum Infect Dis 2020; 7:ofaa257. - PMC - PubMed
    1. Chiang SS, Khan FA, Milstein MB, et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14:947–57. - PubMed
    1. Miftode EG, Dorneanu OS, Leca DA, et al. Tuberculous meningitis in children and adults: a 10-year retrospective comparative analysis. PLoS One 2015; 10:e0133477. - PMC - PubMed